Efficacy of a Nitrogen-Containing Bisphosphonate, Minodronate, in Conjunction With a P38 Mitogen Activated Protein Kinase Inhibitor or Doxorubicin Against Malignant Bone Tumor Cells

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-007-0580-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Metabolism of a Novel Skepinone L-Like P38 Mitogen-Activated Protein Kinase Inhibitor

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2014English

BIRB796, the Inhibitor of P38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells

PLoS ONE
Multidisciplinary
2013English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2014English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2012English

Human P38 Mitogen-Activated Protein Kinase Inhibitor Drugs Inhibit Plasmodium Falciparum Replication

Experimental Parasitology
MedicineParasitologyInfectious DiseasesImmunology
2011English

LY2228820 Dimesylate, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formationin Vitroandin Vivo

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14); X-Box Binding Protein 1 (XBP1)

Science-Business eXchange
2011English

Cutaneous P38 Mitogen-Activated Protein Kinase Activation Triggers Psoriatic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

P38 Mitogen-Activated Protein Kinase in Beryllium-Induced Dendritic Cell Activation

Human Immunology
MedicineAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy